Augmenting Cognitive Function in the Elderly with Mild Cognitive Impairment Using Probiotic <i>Lacticaseibacillus rhamnosus</i> CBT-LR5: A 12-Week Randomized, Double-Blind, Parallel-Group Non-Comparative Study.

Nutrients · 2025 · PMC11858765 · PMID 40005019

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendp = 0.06so close (0.05 < p ≤ 0.1)

Moreover, overall cognitive enhancement was observed in the low-dose group ( p = 0.003), while the high-dose group showed a trend toward improvement ( p = 0.06).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Augmenting Cognitive Function in the Elderly with Mild Cognitive Impairment Using Probiotic &lt;i&gt;Lacticaseibacillus rhamnosus&lt;/i&gt; CBT-LR5: A 12-Week Randomized, Double-Blind, Parallel-Group Non-Comparative Study.

The sentences

Augmenting Cognitive Function in the Elderly with Mild Cognitive Impairment Using Probiotic <i>Lacticaseibacillus rhamnosus</i> CBT-LR5: A 12-Week Randomized, Double-Blind, Parallel-Group Non-Comparative Study.